SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-028928
Filing Date
2018-05-15
Accepted
2018-05-15 16:33:18
Documents
9
Period of Report
2018-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv494189_8k.htm 8-K 25178
2 EXHIBIT 4.1 tv494189_ex4-1.htm EX-4.1 106212
3 EXHIBIT 4.2 tv494189_ex4-2.htm EX-4.2 105527
4 EXHIBIT 4.3 tv494189_ex4-3.htm EX-4.3 111414
5 EXHIBIT 10.1 tv494189_ex10-1.htm EX-10.1 207983
6 EXHIBIT 99.1 tv494189_ex99-1.htm EX-99.1 8792
7 EXHIBIT 99.2 tv494189_ex99-2.htm EX-99.2 8235
8 GRAPHIC tv494189_ex99-1img01.jpg GRAPHIC 19147
9 GRAPHIC tv494189_ex99-2img01.jpg GRAPHIC 19288
  Complete submission text file 0001144204-18-028928.txt   627736
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1029
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 18837096
SIC: 2834 Pharmaceutical Preparations